Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report.
Saved in:
| Title: | Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report. |
|---|---|
| Authors: | Stegemann, Maike1,2 (AUTHOR), Macherndl-Spandl, Sigrid2,3 (AUTHOR), Mairhofer, Mario2 (AUTHOR), Kaltenbrunner, Sabine2 (AUTHOR), Buxhofer-Ausch, Veronika2,3 (AUTHOR), Clausen, Johannes2,3 (AUTHOR), Petzer, Andreas2,3 (AUTHOR), Schmitt, Clemens A.1,2,4,5 (AUTHOR) clemens.schmitt@kepleruniklinikum.at |
| Source: | Leukemia & Lymphoma. Apr2026, Vol. 67 Issue 5, p1147-1151. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2591779 |
